about
NEDD4: a promising target for cancer therapyA novel mutation of the FAT2 gene in spinal meningioma.The hippo pathway in heart development, regeneration, and diseasesMicroRNA expression profiling in male and female familial breast cancer.17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer CellsUnderexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylationIntegrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.Germinal center kinases in immune regulation.Expression analysis of miRNA and target mRNAs in esophageal cancer.Verteporfin inhibits growth of human glioma in vitro without light activationThe clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.Protein salvador homolog 1 acts as a tumor suppressor and is modulated by hypermethylation in pancreatic ductal adenocarcinoma.The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences.1H, 13C, 15N resonance assignment of human YAP 50-171 fragment.Downregulation of YAP inhibits proliferation and induces apoptosis in Eca-109 cells.Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.Late metabolic precursors for selective aromatic residue labeling
P2860
Q27023899-F49106C9-8126-406E-9811-D24911FFB71BQ30369056-E89AD922-1B51-466B-A2FA-0A15FED5BDD1Q34470968-C253978C-9DAB-40B7-86ED-4CEC4AD32F7DQ34687031-A70391A9-D0C4-449B-9B7C-F119E075BB1FQ35206531-F855DE76-3CDC-4562-99AA-F3F78058161BQ36941559-2A06BE96-5522-482B-B674-9B90E1FCED99Q37034046-8A116BFE-7BD4-45C8-BAB7-41BECC636B02Q37718419-105B3B81-0130-4BCF-A2F2-2A42FB409D6EQ37727837-723DCFFD-5024-4711-B659-512210A1F500Q38474114-EBC5C5E4-9439-4187-BE12-B654496E1FD0Q41312032-306B3AED-E8CC-475A-926F-1D5FDA3DE831Q41868661-7DFD8D6C-52EC-4A86-A6E7-9BA40EEB76BCQ41896871-25D3C95E-26F7-46C4-AB15-3A9C85D4FF98Q42362643-0B1AB71D-5F93-460F-BBB4-3CF3F924406CQ44811374-130B5A63-3852-4562-B536-53EC6B5E233DQ48161054-E530530E-A959-4815-BDAA-5628FD31F1FAQ49171030-D4A7A6C9-B87A-4E03-8E18-2326B4A12BA6Q50003436-B97CDFB8-B234-49B2-A0CB-388CCFB65275Q57210356-26DDAC17-B0D4-44B3-BCF7-E18A505CDEF6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regulators of mammalian Hippo pathway in cancer.
@en
type
label
Regulators of mammalian Hippo pathway in cancer.
@en
prefLabel
Regulators of mammalian Hippo pathway in cancer.
@en
P2093
P1476
Regulators of mammalian Hippo pathway in cancer.
@en
P2093
Angela M Liu
John M Luk
Kwong-Fai Wong
Xiaoou Jiang
Yiting Qiao
P304
P356
10.1016/J.BBCAN.2012.05.006
P407
P577
2012-06-07T00:00:00Z